Home Search

cara - search results

If you're not happy with the results, please do another search
marijuana stock news

cara

CARA Stock Chart & Overview Cara Therapeutics is a clinical-stage biotechnology company located in Stamford, CT focused on developing and commercializing new chemical entities designed...
marijuana stocks

Cara Therapeutics, Inc. (CARA) Announces Participation in 2018 Spring Clinical Meetings of the National...

Cara Therapeutics Announces Participation in 2018 Spring Clinical Meetings of the National Kidney Foundation Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and...
marijuana stocks news

Cara Therapeutics (CARA) & Enteris BioPharma, Inc. Doses First Patient in Phase 1...

Enteris BioPharma's "Feasibility-to-Licensing" Partner, Cara Therapeutics, Doses First Patient in Phase 1 Trial of Oral KORSUVA™ Enteris BioPharma, Inc., a biotechnology company developing innovative drug...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Trial of Oral KORSUVA™

Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) Patients Cara Therapeutics, Inc. (CARA), a biopharmaceutical...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) Initiates Pivotal Phase 3 Efficacy Trial of KORSUVA™

  Cara Therapeutics Initiates Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus Cara Therapeutics, Inc. (CARA), a...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Study of Oral CR845

Cara Therapeutics Doses First Patient in Phase 1 Study of Oral CR845 in Non-Hemodialysis Chronic Kidney Disease Patients Cara Therapeutics, Inc. (CARA), a biopharmaceutical company...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) Announces Successful End-of-Phase 2 Meeting with FDA

Cara Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) to Participate in September Medical Meetings

Cara Therapeutics to Participate in September Medical Meetings Data from Phase 2 chronic osteoarthritis pain study of Oral CR845 to be presented in poster session...
marijuana stocks news

Cara Therapeutics, Inc. (CARA) to Webcast Presentation

Cara Therapeutics to Webcast Presentation at the Canaccord Genuity 37th Annual Growth Conference Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing...
marijuana stock news

Cara Therapeutics, Inc. (CARA) Announces Summary Data From Phase 1 Trial of Oral CR845

Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Disease Cara Therapeutics, Inc. (CARA), a biopharmaceutical...

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com